Citi Upgrades Horizon Pharma (HZNP) to Buy
Tweet
Share
E-mail
Get Alerts HZNP Hot Sheet
Price: $116.30 --0%
Rating Summary:
10 Buy, 11 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 12 | New: 13
Rating Summary:
10 Buy, 11 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 12 | New: 13
Join SI Premium – FREE
Citi upgraded Horizon Pharma (NASDAQ: HZNP) from Neutral to Buy.
For an analyst ratings summary and ratings history on Horizon Pharma click here. For more ratings news on Horizon Pharma click here.
Shares of Horizon Pharma closed at $21.49 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Keefe, Bruyette & Woods Upgrades Trustmark (TRMK) to Outperform
- Deutsche Bank Upgrades Acadia Healthcare (ACHC) to Hold 'on a neutral risk/ reward'
- Goldman Sachs Upgrades The TJX Companies (TJX) to Buy, 'best-in-class operator'
Create E-mail Alert Related Categories
UpgradesRelated Entities
CitiSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
